After reading the latest MD&A, margins are still getting squeezed by input costs and rand weakness. The see…by @thuli_dd on $CKS

After reading the latest MD&A, margins are still getting squeezed by input costs and rand weakness. The seed and agri input distribution model is solid but CKS needs volume growth to offset that, otherwise we're just treading water at R19.76. Key takeaway for me is whether they can actually grow market share in the next two years or if this stays a dividend play for patient holders.